Cite
MLA Citation
David Cameron et al.. “Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.” Lancet oncology, vol. 18, no. 7, n.d., pp. 929–945. http://access.bl.uk/ark:/81055/vdc_100046945497.0x000017